Vir Biotechnology (VIR) Shares Surge Following Positive Clinical Trial Results
Fahim Awan
June 5, 2024
After demonstrating a high virologic response and ALT normalization in a clinical trial, shares of Vir Biotechnology, Inc. (NASDAQ: VIR) are experiencing a significant rise